| Bioactivity | TCV-309 is an antagonist for platelet activating factor (PAF). TCV-309 improves the left ventricular function during ischemia-reperfusion (77.6% recover at 1 μM), protects the cardiac function[1]. |
| CAS | 131311-25-6 |
| Formula | C30H34BrN5O7 |
| Molar Mass | 656.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Katoh S, et al., Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309. Cardiovasc Res. 1993 Aug;27(8):1430-4. |
TCV-309
CAS: 131311-25-6 F: C30H34BrN5O7 W: 656.52
TCV-309 is an antagonist for platelet activating factor (PAF). TCV-309 improves the left ventricular function during isc
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.